Core Viewpoint - The article discusses the evolution of the "medical-research co-creation" trend in the Chinese beauty market, highlighting how brands like La Roche-Posay are leveraging scientific research to differentiate themselves and achieve significant sales growth, particularly in the context of the brand's 50th anniversary [2][4]. Group 1: Brand Performance and Market Position - La Roche-Posay has achieved over €7 billion in sales, marking a significant milestone for L'Oréal's dermatological division, and has become the third-largest skincare brand globally and the most recommended by dermatologists [2][4]. - The brand's unique heritage, rooted in the therapeutic properties of its thermal spring water, has been a key factor in its success, with a history dating back to the 14th century [7][9]. - The brand has submitted 180 research papers and actively participates in global dermatology conferences, reinforcing its position as a leader in skincare science [12][19]. Group 2: Research and Development - La Roche-Posay has a strong commitment to scientific research, having pioneered several innovations in skincare, including the first sunscreen with anti-UVA properties in 1987 and the first microbiome research in 2011 [10][12]. - The brand collaborates with dermatologists and medical experts to develop products that address real skin issues, emphasizing a holistic approach to skincare that includes emotional and psychological aspects [13][14]. Group 3: Market Strategy in China - Since entering the Chinese market in 2001, La Roche-Posay has positioned itself as a pioneer in scientific skincare, rapidly becoming the third-largest market for the brand globally [15][24]. - The brand's sales in China are projected to exceed ¥2.3 billion in 2024, reflecting a 12% year-on-year growth, driven by high repurchase rates of key products [15][24]. - La Roche-Posay has established a robust "medical-research co-creation" system in China, resulting in significant product innovations tailored to local consumer needs [21][24]. Group 4: Social Responsibility and Community Engagement - The "Blue Ribbon" initiative launched in 2022 aims to support skin health for cancer patients, showcasing the brand's commitment to social responsibility and community engagement [26][27]. - La Roche-Posay actively participates in educational campaigns and collaborations with local medical institutions to raise awareness about skin health issues related to cancer treatment [26][27]. Group 5: Consumer Trends and Brand Positioning - The article highlights a shift in consumer behavior towards more informed and rational purchasing decisions, with an increasing focus on ingredient transparency and product efficacy [29][31]. - La Roche-Posay's branding emphasizes a consistent message of professionalism and care, resonating with consumers who prioritize both effectiveness and a human touch in skincare [28][31].

欧莱雅在上述声明中表示，在过去三年复杂的市场环境下，孟颖琪带领理肤泉团队持续提升市场份 额，强化了标志性的B5修护系列产品，使B5修护霜和面膜成为公司最畅销的招新产品之一。 经历了2023年的双位数增长之后，欧莱雅皮肤科学美容部门增速放缓明显。接近欧莱雅的人士向36氪 透露，国内对"皮肤学级护肤品市场推广监管严苛"，尤其涉及到医师推荐等敏感字眼。欧莱雅在相关 产品的市场推广过程中将合规性放在首位，这在一定程度上制约了发展。 欧莱雅中国官网显示，皮肤科学美容部门的商业模式主要建立在"医生推荐基础上"，扩大与健康领域 专家的合作关系对部门品牌的发展至关重要。上述人士认为，相比国内一些主攻皮肤学级的护肤品 牌，欧莱雅在医院、诊所等渠道的渗透率还不够。 履职理肤泉中国三年。 作者 | 贺哲馨 编辑 | 乔芊 36氪独家获悉，欧莱雅宣布理肤泉中国品牌总经理（General Manager）孟颖琪为巴黎欧莱雅中国品牌 总经理，该任命将于2025年4月1日正式生效。 公开资料显示，孟颖琪毕业于复旦大学新闻学院广告系，以管培生的身份于2009年加入欧莱雅中国， 一开始负责植村秀品牌的客户管理、网络推广和销售等工作。之后，孟颖 ...